Divis Laboratories Competitors and Similar CompaniesClear all

Divis Laboratories's competitors and similar companies include Lonza, Teva and Hikma Pharmaceuticals.

	Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.	Lonza Lonza Group is a company specializing in life sciences and biotechnology solutions	Teva Teva is a pharmaceuticals company.	Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.
Founding Date	Founding Date 1990	Founding Date 1897	Founding Date 1901	Founding Date 1978
Type	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare pharma	Tags Healthcare biotech chemicals life sciences pharma	Tags Healthcare pharma	Tags Healthcare pharma
Locations	Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US	Locations Basel, CH HQ Baulkham Hills, AU Antwerpen, BE Bornem, BE Verviers, BE Rio De Janeiro, BR Dorval, CA see more	Locations HQ	Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more
Employees	Employees 7,9267% increase	Employees 19,7712% increase	Employees 29,780	Employees 9,500
Financial
Revenue (est.)	Revenue (est.) ₹105.6b (FY, 2026)	Revenue (est.) CHF6.5b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $3.3b (FY, 2025)
Cost of goods	Cost of goods ₹40.9b (FY, 2026)	Cost of goods CHF2.1b (FY, 2025)	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)
Gross profit	Gross profit ₹69.7b (FY, 2026)	Gross profit CHF4.5b (FY, 2025)	Gross profit N/A	Gross profit $1.7b (FY, 2025)
Net income	Net income ₹25.7b (FY, 2026)	Net income CHF909m (FY, 2025)	Net income N/A	Net income $407m (FY, 2025)